相关实验视频
Updated: Jul 11, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
[METTL3抑制剂STM2457通过调节小鼠的线粒体功能来改善与代谢功能障碍相关的脂肪肝疾病]
1Department of Clinical Laboratory Medicine, First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan 250014, China.
甲基转移酶类3 (METTL3) 抑制剂STM2457有效治疗小鼠的代谢功能障碍相关的脂肪肝疾病 (MAFLD). 这种化合物减少肝脏脂肪,改善胰岛素敏感性,并保护线粒体免受损伤.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018